2-Methyl-3-Nitrophenylacetic Acid CAS 23876-15-5 Purity >99.5% (HPLC) Ropinirole Hydrochloride Intermediate
Manufacturer Supply With High Quality, Commercial Production
Chemical Name: 2-Methyl-3-Nitrophenylacetic Acid CAS: 23876-15-5
| Chemical Name | 2-Methyl-3-Nitrophenylacetic Acid |
| Synonyms | 2-Methyl-3-Nitro-Benzeneacetic Acid; Ropinirole Intermediate 1; (3-Nitro-o-tolyl)acetic Acid; 2-(2-methyl-3-nitrophenyl)acetic acid |
| CAS Number | 23876-15-5 |
| CAT Number | RF-PI1196 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C9H9NO4 |
| Molecular Weight | 195.17 |
| Melting Point | 131.0~136.0℃ |
| Solubility | Soluble in Methanol |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | Off-White or Pale Yellow Powder |
| Purity / Analysis Method | >99.5% (HPLC) |
| Melting Point | 130.0~137.0℃ |
| Loss on Drying | <0.50% |
| Single Impurity | ≤0.20% |
| Total Impurities | <0.50% |
| Test Standard | Enterprise Standard |
| Usage | Intermediate of Ropinirole Hydrochloride (CAS: 91374-20-8) |
Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.
2-Methyl-3-Nitrophenylacetic Acid (CAS: 23876-15-5) is an intermediate of Ropinirole Hydrochloride (CAS: 91374-20-8). Ropinirole Hydrochloride was launched in the UK as a monotherapy or in combination with low-dose levodopa for the treatment of early-stage idiopathic Parkinson's disease. Ropinirole Hydrochloride is also used for the treatment of moderate to severe Restless Legs Syndrome (RLS). FDA approved the first generic drug of Ropinirole Hydrochloride, developed by GlaxoSmithKline(GSK). An antiparkinsonian agent. A selective dopamine D2-receptor agonist.
